(Total Views: 57)
Posted On: 12/21/2023 3:39:11 PM
Post# of 41479
![Avatar](https://investorshangout.com/images/ProfileImages/734810790_1098_wst.png)
$RNXT The pivotal Phase III CouGar study will be the second clinical trial evaluating RenovoGem™, a combination drug-device product, in a difficult-to-access solid tumor cancer. Learn more: https://bit.ly/4asSZjH
$RNXT #BileDuctCancer https://twitter.com/RenovoRx/status/1737914614195577273
$RNXT #BileDuctCancer https://twitter.com/RenovoRx/status/1737914614195577273
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)